Market revenue in 2022 | USD 334.7 million |
Market revenue in 2030 | USD 1,507.0 million |
Growth rate | 20.7% (CAGR from 2022 to 2030) |
Largest segment | Cell therapy |
Fastest growing segment | Gene Therapy |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gene Therapy, Cell Therapy |
Key market players worldwide | Lonza Group Ltd, Bluebird bio Inc, Catalent Inc, Roche, Samsung BioLogics, Boehringer Ingelheim, Hitachi Ltd, Takara Bio Inc, Miltenyi Biotec, Thermo Fisher Scientific Inc, Novartis AG ADR, Merck KGaA, Wuxi AppTec Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy manufacturing market will help companies and investors design strategic landscapes.
Cell therapy was the largest segment with a revenue share of 67.02% in 2022. Horizon Databook has segmented the Latin America cell and gene therapy manufacturing market based on gene therapy, cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Latin American region has low penetration of cell and gene therapy manufacturing market. However, developing biotechnology and biopharmaceutical industries in the Latin American countries are anticipated to increase demand for cell and gene therapy manufacturing in the region.
The region is witnessing increasing attention and fast growth in the field of stem cell research. Scientists from several Latin American countries, such as Mexico, Uruguay, Chile, Brazil, and Argentina, are working on stem cell research.
Thus, active engagement in this space is expected to boost market growth. In addition, Latin America is considered a growing market for cell and gene therapy products, as the incidence of chronic diseases is high in the Latin American countries, which, in turn, is expected to drive demand for manufacturing services.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America cell and gene therapy manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America cell and gene therapy manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account